BioNTech SE ADR [BNTX] stock prices are up 1.27% to $90.15 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BNTX shares have gain 2.21% over the last week, with a monthly amount glided 13.40%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
BioNTech SE ADR [NASDAQ: BNTX] stock has seen the most recent analyst activity on August 07, 2024, when Deutsche Bank upgraded its rating to a Buy but kept the price target unchanged to $95 for it. Previously, HSBC Securities upgraded its rating to Buy on August 02, 2024. On May 14, 2024, Evercore ISI initiated with a In-line rating and assigned a price target of $100 on the stock. BMO Capital Markets started tracking the stock assigning a Outperform rating and suggested a price target of $127 on February 23, 2024. Oppenheimer initiated its recommendation with a Perform. JP Morgan downgraded its rating to Underweight for this stock on December 01, 2023, and downed its price target to $99. In a note dated October 16, 2023, HSBC Securities downgraded an Hold rating on this stock and revised its target price from $124 to $111.
The stock price of BioNTech SE ADR [BNTX] has been fluctuating between $76.53 and $122.95 over the past year. Currently, Wall Street analysts expect the stock to reach $153.67 within the next 12 months. BioNTech SE ADR [NASDAQ: BNTX] shares were valued at $90.15 at the most recent close of the market. An investor can expect a potential return of 70.46% based on the average BNTX price forecast.
Analyzing the BNTX fundamentals
The BioNTech SE ADR [NASDAQ:BNTX] reported sales of 2.91B for trailing twelve months, representing a drop of -24.09%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.23%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.19%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.03 and Total Capital is -0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 88.77 points at the first support level, and at 87.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 91.61, and for the 2nd resistance point, it is at 93.06.
Ratios To Look Out For
It’s worth pointing out that BioNTech SE ADR [NASDAQ:BNTX]’s Current Ratio is 7.54. Also, the Quick Ratio is 7.40, while the Cash Ratio stands at 4.28. Considering the valuation of this stock, the price to sales ratio is 7.37, the price to book ratio is 1.05.
